Empiric Intraperitoneal Antibiotics for CAPD Peritonitis
For empiric treatment of CAPD peritonitis, use intraperitoneal vancomycin (15-30 mg/kg loading dose, then maintenance dosing) combined with either ceftazidime (1000-1500 mg per exchange) or cefepime (1000-2000 mg per exchange), administered intraperitoneally. 1, 2
Rationale for First-Line Empiric Therapy
The optimal empiric regimen must provide broad-spectrum coverage against both gram-positive organisms (which cause approximately 70% of CAPD peritonitis) and gram-negative bacteria (responsible for about 25% of cases) 3.
Key antibiotic combination:
- Vancomycin is the preferred gram-positive agent because it covers methicillin-resistant staphylococci and provides reliable coverage of skin flora that commonly contaminate PD systems 1, 4
- Ceftazidime or cefepime provides gram-negative coverage, including Pseudomonas aeruginosa, which is critical given the severe outcomes associated with pseudomonal peritonitis 1, 2
Specific Dosing Recommendations
Vancomycin dosing (intraperitoneal):
- Loading dose: 15-30 mg/kg body weight in one exchange 1
- Maintenance: Can be administered once weekly (1000 mg per exchange) for convenience, which avoids aminoglycoside toxicity while maintaining effectiveness 1
Ceftazidime dosing (intraperitoneal):
Alternative: Cefepime can substitute for ceftazidime with similar efficacy 2
Why This Regimen Over Alternatives
Avoid aminoglycosides as first-line therapy. While gentamicin combined with cefazolin was historically used 5, the vancomycin/ceftazidime combination is superior because:
- It avoids aminoglycoside ototoxicity and nephrotoxicity, which are particularly problematic in dialysis patients 1
- Provides better coverage against resistant gram-positive organisms 1
- Allows for less frequent dosing with vancomycin (once weekly vs. daily aminoglycoside monitoring) 1
The cefazolin/ceftazidime combination (used in 40% of cases in recent practice) is acceptable but provides inferior gram-positive coverage compared to vancomycin, particularly against methicillin-resistant organisms 2
Route of Administration
Intraperitoneal administration is strongly preferred over intravenous therapy for CAPD peritonitis because:
- Achieves higher local drug concentrations in the peritoneal cavity 3
- Results in 70-80% cure rates with outpatient management 3
- Allows patients to continue dialysis while treating infection 3
Treatment Duration and Monitoring
- Initial empiric therapy duration: Continue until culture results return (typically 48-72 hours) 2, 6
- Adjust antibiotics based on culture and sensitivity results once available 2, 6
- Total treatment duration: Typically 14 days for most organisms, though this should be tailored based on clinical response and causative organism 4, 6
- Monitor clinical response by assessing dialysate clarity and white blood cell count in effluent; treatment can be discontinued when WBC is <100/μL for 3 consecutive days 5
Important Caveats
Fungal peritonitis requires immediate catheter removal. If Candida or other fungi are identified, antibiotic therapy alone is insufficient and the PD catheter must be removed to achieve cure 3
Pseudomonas peritonitis often requires catheter removal in addition to antibiotics for successful treatment 3
Tunnel infections or exit-site infections causing peritonitis have lower cure rates (approximately 14% treatment failure) and may require catheter removal 5, 7
Consider local antibiotic resistance patterns. In areas with high rates of vancomycin-resistant enterococci or ceftazidime-resistant gram-negatives, empiric regimens may need modification based on institutional antibiograms 2, 6